$1.21
-0.015-1.23%
Last update: Oct 30, 4:34 AM
Cellectar Biosciences Inc (CLRB) Stock Price, Quote, News & History
CLRBNASDAQ
Biotechnology investing is a strange corner of the market. A company can own a drug that may eventually produce billions of dollars in sales and still find...
You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.
Other companies in Cellectar Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Cellectar Biosciences has a consensus price target of $286.67.
The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $1.18 last updated October 30, 2026 at 4:34 AM EDT.
There are no upcoming dividends for Cellectar Biosciences.
Cellectar Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Cellectar Biosciences.
Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid...
